Skip to main content

Table 3 Differentially expressed mRNAs in metastatic tissue compared with primary OC tissue

From: High-throughput sequencing identification of differentially expressed microRNAs in metastatic ovarian cancer with experimental validations

Genes

Metastatic (2−ΔCt)

Primary (2−ΔCt)

P value

Fold change

BCL2L1

4.70E−02

2.30E−02

0.047085

2.07

TGFβ2

2.00E−03

3.50E−04

0.017231

5.68

TNC

5.20E−02

2.50E−03

0.006661

20.7

HOXB5

6.10E−04

1.00E−04

0.035099

6.11

HOXB7

1.20E−02

2.50E−03

0.033375

4.9

HOXB8

4.10E−02

5.70E−03

0.046631

7.19

ITGB3

5.60E−03

1.40E−03

0.021938

3.9

MTSS1

5.10E−03

1.00E−03

0.034451

5.08

FOXA2

1.70E−05

1.10E−04

0.034065

− 6.48

PAK1

2.60E−03

5.40E−03

0.006704

− 2.04

  1. BCL2L1 B-cell CLL/lymphoma 2-like 1, TGFβ2 transforming growth factor beta 2, TNC tenascin-C, HOX homeobox, ITGB3 integrin beta-3, MTSS1 metastasis suppressor 1, FOXA2 forkhead box A2, PAK1 p21-activated kinase, OC ovarian cancer